Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N ATKINSON

Showing results (211-220 of 262) with videos related to

Pageof 27
Sort By:
Science (New York, N.Y.)|February 9, 2018
High-energy, high-fat lifestyle challenges an Arctic apex predator, the polar bearA M Pagano, G M Durner, K D Rode, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasiaI V Boiko, M F Mitchell, D K Pandey, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Gut microbiota and metabolites drive chronic sickle cell disease painKatelyn E Sadler, Samantha N Atkinson, Vanessa L Ehlers, et al.
Global Change Biology|September 23, 2020
Transient benefits of climate change for a high-Arctic polar bear (Ursus maritimus) subpopulationKristin L Laidre, Stephen N Atkinson, Eric V Regehr, et al.
Cancer|December 11, 1999
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinomaD M Gershenson, M Morris, T W Burke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neckJ Paredes, W K Hong, T B Felder, et al.
Cancer Research|December 25, 2002
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathwayJia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2025
Regulated coexpression of PrP from different species in mice impacts the replication and host range properties of prion strainsJoseph P DeFranco, Jifeng Bian, Sehun Kim, et al.
Pageof 27

Showing results (211-220 of 262) with videos related to

Sort By:
Pageof 27
Science (New York, N.Y.)|February 9, 2018
High-energy, high-fat lifestyle challenges an Arctic apex predator, the polar bearA M Pagano, G M Durner, K D Rode, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasiaI V Boiko, M F Mitchell, D K Pandey, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 12, 2001
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years laterC F Verschraegen, M Benjapibal, W Supakarapongkul, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Gut microbiota and metabolites drive chronic sickle cell disease painKatelyn E Sadler, Samantha N Atkinson, Vanessa L Ehlers, et al.
Global Change Biology|September 23, 2020
Transient benefits of climate change for a high-Arctic polar bear (Ursus maritimus) subpopulationKristin L Laidre, Stephen N Atkinson, Eric V Regehr, et al.
Cancer|December 11, 1999
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinomaD M Gershenson, M Morris, T W Burke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neckJ Paredes, W K Hong, T B Felder, et al.
Cancer Research|December 25, 2002
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathwayJia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2025
Regulated coexpression of PrP from different species in mice impacts the replication and host range properties of prion strainsJoseph P DeFranco, Jifeng Bian, Sehun Kim, et al.
Pageof 27